Development of Nanogels/Microgels for Regenerative Medicine
A special issue of Gels (ISSN 2310-2861). This special issue belongs to the section "Gel Applications".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 1459
Special Issue Editors
Interests: regenerative medicine; immunology; cell reprogramming
Special Issue Information
Dear Colleagues,
In recent years, enormous growth in nano-material technology and science has been attained in the biomedical filed. For example, nanosized hydrogels, so-called nanogels, have been reported to provide a feasible drug-delivery system that enables the efficient transfer of chemotherapeutics and short interfering RNA, and slow-release anti-bacterial peptide, growth factors and cytokines on-site. Through the functions, nanogels can inhibit tumor growth, and enhance wound-healing and blood vessel regeneration. Moreover, nanogels are also used as a scaffold for tissue engineering, including bone, cardiac and urethra tissue regeneration. In general, nanogels are highly biocompatible and biodegradable. Nanogels are also considered to be excellent scaffolds for preparing composites as a novel class of advanced materials, which comprise both nanogels and other constituents, such as polymers or inorganic nanoparticles. Thus, the development of nanogels and their effective application will play an important role in the regenerative medicine field.
This Special Issue will provide various reports on the leading edge nanogels’ synthesis and their effective application in regenerative medicine.
Dr. Kenta Yamamoto
Dr. Yuanhui Song
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Gels is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanogels
- regenerative medicine
- gel application
- medical field
- RNAi transfer
- growth factor release
- biomedical scaffolds
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Glucan dendrimer-nanogel mediated OC-STAMP silencing for treatment of pathogenic bone resorption
Authors: Kenta Yamamoto; Shin-Ichi Sawada; Osam Mazda; Kazunari Akiyoshi; Toshihisa Kawai
Affiliation: 1 Department of Immunology, Kyoto Prefectural University of Medicine
2 Department of Oral Science and Translational Research, College of Dental Medicine, Nova Southeastern University
3 Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University
4 Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University
Abstract: Osteoclasts-stimulatory trans-membrane protein (OC-STAMP) plays a pivotal role in promotion of cell fusion event during osteoclast-differentiation (osteoclastogenesis) in the context of pathogenic bone resorption. Thus, it is plausible that the bioengineered approach that suppresses OC-STAMP expression can lead to the development of an effective treatment for inflammatory bone resorption diseases, with minimum side effects. Here, we compared two types of novel amphiphilic glucan dendrimer (GD) nanogels (with or without C12) as a carrier of short interfering RNA (siRNA) to silence OC-STAMP. The results showed that C12-GD nanogels is more efficient in the in vitro silencing of OC-STAMP than GD-nanogel, and that local injection of anti-OC-STAMP-siRNA /C12-GD nanogel complex could attenuate bone resorption induced in the mouse model of periodontitis.
Title: Nanogel Engineering for Development of Novel Immunotherapy and Regenerative medicine
Authors: Testuya Adachi
Affiliation: Department of Dental Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine